Your browser doesn't support javascript.
loading
Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines.
Amano, Masayuki; Ichikawa, Yasuko; Uemura, Yukari; Matsumoto, Shota; Maeda, Kenji; Matsushita, Shuzo; Shimada, Shinya; Mitsuya, Hiroaki.
Affiliation
  • Amano M; Department of Clinical Retrovirology, Joint research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. Electronic address: mamano@kumamoto-u.ac.jp.
  • Ichikawa Y; Kumamoto General Hospital, Japan Community Health Care Organization, Kumamoto, Japan.
  • Uemura Y; Department of Data Sciences, Center for Clinical Sciences, National Center for Global Health and Medicine (NCGM), Tokyo, Japan.
  • Matsumoto S; Kumamoto General Hospital, Japan Community Health Care Organization, Kumamoto, Japan.
  • Maeda K; Department of Refractory Viral Infections, NCGM Research Institute, Tokyo, Japan.
  • Matsushita S; Department of Clinical Retrovirology, Joint research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Shimada S; Kumamoto General Hospital, Japan Community Health Care Organization, Kumamoto, Japan.
  • Mitsuya H; Department of Refractory Viral Infections, NCGM Research Institute, Tokyo, Japan.
J Infect ; 86(5): e130-e132, 2023 05.
Article in En | MEDLINE | ID: mdl-36736492
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Humans Language: En Journal: J Infect Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Humans Language: En Journal: J Infect Year: 2023 Document type: Article